Advertisement
Canada markets closed
  • S&P/TSX

    22,167.03
    +59.95 (+0.27%)
     
  • S&P 500

    5,254.35
    +5.86 (+0.11%)
     
  • DOW

    39,807.37
    +47.29 (+0.12%)
     
  • CAD/USD

    0.7387
    +0.0001 (+0.01%)
     
  • CRUDE OIL

    83.11
    -0.06 (-0.07%)
     
  • Bitcoin CAD

    95,840.63
    +1,762.46 (+1.87%)
     
  • CMC Crypto 200

    885.54
    0.00 (0.00%)
     
  • GOLD FUTURES

    2,254.80
    +16.40 (+0.73%)
     
  • RUSSELL 2000

    2,124.55
    +10.20 (+0.48%)
     
  • 10-Yr Bond

    4.2060
    +0.0100 (+0.24%)
     
  • NASDAQ futures

    18,465.00
    -38.75 (-0.21%)
     
  • VOLATILITY

    13.01
    +0.23 (+1.80%)
     
  • FTSE

    7,952.62
    +20.64 (+0.26%)
     
  • NIKKEI 225

    40,407.03
    +238.96 (+0.59%)
     
  • CAD/EUR

    0.6853
    +0.0010 (+0.15%)
     

Is Now the Time for Income Investors to Buy This Big Pharma Stock?

Is Now the Time for Income Investors to Buy This Big Pharma Stock?

Much of that debt of gratitude for being able to return to normalcy is owed to the pharmaceutical behemoth Pfizer (NYSE: PFE). Let's dive into Pfizer's fundamentals and valuation to see if we can address this question. Since its founding in 1849, Pfizer has grown into a gargantuan business.